Clinical Trial Update: A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating the effectiveness and safety of JS1-1-01 Tablet for moderate-to-severe depression; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JS1-1-01 Tablet

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Depression | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING